(Reuters) - The recommendations, proposed in March 2006, were designed to help manufacturers use newer technology that allows vaccines to be made faster once a strain of flu is identified, and to encourage more companies to get into the vaccine business.
"Having additional manufacturers of licensed influenza vaccines will enhance the capacity to produce more doses of seasonal influenza vaccines, as well as contribute to the nation's pandemic preparedness, one of our top priorities," said Jesse Goodman, director of the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research.
Read more at Reuters.com Government Filings News
"Having additional manufacturers of licensed influenza vaccines will enhance the capacity to produce more doses of seasonal influenza vaccines, as well as contribute to the nation's pandemic preparedness, one of our top priorities," said Jesse Goodman, director of the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment